Latest News
June 2023: Cancer is the leading cause of death worldwide. An estimated 18 million cases were reported in 2020[1], and the incidence rate of the disease is predicted to increase… Continue reading “What 555 Cancer Patients Groups Say about the Corporate Reputation of Pharma in 2022”
May 2023: Now in its 12th year, PatientView’s Corporate Reputation of Pharma survey remains one of the few studies that explore the opinions of patient groups globally on whether pharmaceutical… Continue reading “What 2000+ patient groups worldwide say about pharma in 2022”
February 2023: The role of patient advocacy groups has become more consequential as patients and their families take an active role in their care. However, in the case of rare… Continue reading “Powerful Patient Advocacy: Advocating for people with rare and undiagnosed diseases”
February 2023: Patient groups are organisations formed by advocates with the goal of ensuring the best outcomes for patients. As one of the only stakeholders to network with every element… Continue reading “All about patient groups and how we work with them”
February 2023: The role of patient advocacy groups has become more salient as patients and their families take a more active role in their care. Patient groups are dedicated to… Continue reading “Powerful Patient Advocacy: Helping to reduce the cancer burden in South Africa”
January 2023: The role of patient advocacy groups has become more salient as patients and their families take a more active role in their care. Patient groups are dedicated to… Continue reading “Powerful Patient Advocacy: The lasting legacy of ACT UP”
December 2022: PatientView’s Corporate Reputation of Pharma survey is now open for patient group participation, as it enters its 12th year of publication. The final survey report, including patient feedback… Continue reading “Methodology Changes and 2021 Reports: Corporate Reputation of Pharma 2022”
August 2022: PatientView have released a first-of-its-kind report which reveals the patient perspective on the pharma industry and ESG. This blog shares one case study from the report and explores… Continue reading “ESG and Aerosol inhalers: can health systems use environmentally sustainable treatments and still be truly patient-centric?”
June 2022: New research published by PatientView shares how patient groups rank the pharma industry and individual companies by their ESG practices. A term created by the United Nations Global… Continue reading “Patient groups provide a new perspective on Environmental, Social and Governance (ESG) policy within pharma”
June 2022: The report into this research, and an accompanying webinar, have been released into the public domain without copyright, to support patient advocacy groups that have an interest in… Continue reading “Patient groups will play a vital role in patients getting a timely diagnosis of Alzheimer’s disease”
